EUVIMEDEUVIMED entdecken
Crossref

Vancomycin in Renal Dialysis Patients: Achievement of Therapeutic Concentration and Prevention of Toxicity

Fatima Y. Mohammed, Maisaa Y. Mohamed

International Journal of Environmental and Biological Sciences · 31.07.2026 · 1 (3)

DOI: 10.63939/wq024z21 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Environmental and Biological Sciences, online erschienen am 31.07.2026. Verfasst von Fatima Y. Mohammed und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vancomycin is used in hemodialysis patients to treat infection with Staphylococcus aureus. Serum concentration below therapeutic level might encourage bacterial resistance and treatment failure.

Objectives

The current study aimed to investigate the effect of successive dialysis sessions on the level of vancomycin in the blood serum and to evaluate the safety of the treatment in patients with chronic kidney failure. Methodology: Twenty-four patients receiving different vancomycin dosage regimens were included. Patients attending Renal Dialysis Center at Basrah General Hospital (Basrah, Iraq) and receiving vancomycin were recruited for this study. Vancomycin concentration was measured, using fluorescence polarization immunoassay technique, in three consecutive dialysis sessions, and immediately prior to the fourth one. Serum creatinine and absolute neutrophil count was measured prior to treatment and after completing vancomycin doses through therapeutic drug monitoring.

Results

Trough vancomycin blood concentration in eleven patients receiving 500mg vancomycin during the last half hour of hemodialysis session twice, thrice weekly or when combined together, did not reach the lower recommended concentration of 15 µg/ml in 90.5 %, 78.9% and 85% of the samples respectively. There were trends toward higher concentration with increasing BMI and with creatinine clearance of

Zitieren

APA

Mohammed, F. Y., & Mohamed, M. Y. (2026). Vancomycin in Renal Dialysis Patients: Achievement of Therapeutic Concentration and Prevention of Toxicity. International Journal of Environmental and Biological Sciences, 1(3). https://doi.org/10.63939/wq024z21

Vancouver

Mohammed FY, Mohamed MY. Vancomycin in Renal Dialysis Patients: Achievement of Therapeutic Concentration and Prevention of Toxicity. International Journal of Environmental and Biological Sciences. 2026;1(3). doi:10.63939/wq024z21

BibTeX
@article{Mohammed2026,
  author = {Mohammed, Fatima Y. and Mohamed, Maisaa Y.},
  title = {Vancomycin in Renal Dialysis Patients: Achievement of Therapeutic Concentration and Prevention of Toxicity},
  journal = {International Journal of Environmental and Biological Sciences},
  year = {2026},
  volume = {1},
  number = {3},
  doi = {10.63939/wq024z21}
}
Kostenlos starten →